NEW YORK (Reuters Health) – Consistent with some previous reports, the results of a case-control study suggest that depressive symptoms are an early feature of Parkinson’s disease, preceding…
NEW YORK (Reuters Health) – Although schizophrenia is associated with an increased risk of violent crime, after accounting for substance abuse, the risk is relatively small, according to…
NEW YORK (Reuters Health) – Antipsychotic medications and lifestyle factors cannot fully explain the elevated risk for cardiovascular disease (CVD) observed in patients with schizophrenia spectrum disorders, according…
David Kloth, MD, is the Founder, President and Medical Director of Connecticut Pain Care, P.C., a pain management center for the treatment of acute and chronic pain. He…
David Kloth, MD, is the Founder, President and Medical Director of Connecticut Pain Care, P.C., a pain management center for the treatment of acute and chronic pain. He…
NEW YORK (Reuters Health) – New research suggests that spinal fluid levels of three biomarkers may help identify people with very mild dementia of the Alzheimer type (DAT)…
NEW YORK (Reuters Health) – Elderly individuals with cognitive impairment may be more likely than those with intact cognitive function to have early age-related macular degeneration (AMD), according…
NEW YORK (Reuters Health) – In women with severe premenstrual syndrome (PMS), sertraline therapy for 4 months rather than for 12 months is associated with a higher relapse…
NEW YORK (Reuters Health) – Infants born to mothers with depression are at increased risk for sleep disturbances from 2 to 24 weeks of age, according to a…
NEW YORK (Reuters Health) – A recent prospective study disproves earlier observations that non-steroidal anti-inflammatory drugs (NSAIDS) prevent Alzheimer dementia (AD). At best, NSAIDS may delay its onset,…